FDA Steps Back From Medical AI as California Steps In
Washington is loosening oversight of clinical AI while California and other states draft their own rules. A physician weighs in on what comes next for AI in medicine.
- FDA is reducing oversight of AI systems used in clinical care
- California and other states are writing their own medical AI rules
- A physician assesses the impact on clinics and patients
Read next
Business